{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04278651",
            "orgStudyIdInfo": {
                "id": "19G.929"
            },
            "organization": {
                "fullName": "Thomas Jefferson University",
                "class": "OTHER"
            },
            "briefTitle": "Early Antenatal Support for Iron Deficiency Anemia",
            "officialTitle": "Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy",
            "acronym": "EASI-A",
            "therapeuticArea": [
                "Women's Health",
                "Other"
            ],
            "study": "early-antenatal-support-for-iron-deficiency-anemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-02-04",
            "studyFirstSubmitQcDate": "2020-02-18",
            "studyFirstPostDateStruct": {
                "date": "2020-02-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Thomas Jefferson University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Auerbach Hematology and Oncology",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.",
            "detailedDescription": "Pregnant singletons diagnosed with iron deficiency anemia will be enrolled between 14-24 weeks and will be randomized 1:1 to either a course of ferumoxytol (510mg x 2 doses 3-8 days apart) or oral iron (325mg) twice daily."
        },
        "conditionsModule": {
            "conditions": [
                "Pregnancy Related",
                "Anemia, Iron Deficiency",
                "Anemia of Pregnancy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Randomized controlled trial",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Oral Iron",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "325mg oral iron (ferrous sulfate) twice daily",
                    "interventionNames": [
                        "Drug: Ferrous Sulfate"
                    ]
                },
                {
                    "label": "Intravenous Iron",
                    "type": "EXPERIMENTAL",
                    "description": "510mg ferumoxytol intravenous infusion for two doses total; second dose 3-8 days after first dose.",
                    "interventionNames": [
                        "Drug: Ferumoxytol"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ferumoxytol",
                    "description": "510mg infusion x 2 doses 3-8 days apart",
                    "armGroupLabels": [
                        "Intravenous Iron"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ferrous Sulfate",
                    "description": "325mg oral twice daily",
                    "armGroupLabels": [
                        "Oral Iron"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Hemoglobin",
                    "description": "Change in hemoglboin at day 90 following treatment initiation",
                    "timeFrame": "90 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Anemia resolution",
                    "description": "Percent of participants in each group with Hb\\>=11.0 at day 90",
                    "timeFrame": "90 days"
                },
                {
                    "measure": "Anemia at Delivery",
                    "description": "Percent of participants in each group with Hb\\>=11.0 at delivery",
                    "timeFrame": "9 months"
                },
                {
                    "measure": "Need for additional therapy",
                    "description": "Percent of participants in each group requiring additional therapy for iron deficiency anemia after 28 weeks",
                    "timeFrame": "9 months"
                },
                {
                    "measure": "Quality of life scale",
                    "description": "Linear Analogue Scale Assessment",
                    "timeFrame": "30, 60, 90 days"
                },
                {
                    "measure": "Adherence",
                    "description": "adherence to assigned group. Measured by what % of IV infusions completed of the two required in IV iron group, and for oral iron group, what %pills taken/prescribed based on pill counts",
                    "timeFrame": "90 days"
                },
                {
                    "measure": "Need for post partum transfusion",
                    "description": "Incidence of transfusion after delivery/post partum",
                    "timeFrame": "9 months"
                },
                {
                    "measure": "Neonatal outcomes: cord blood iron indices",
                    "description": "Hb, ferritin, total iron saturation",
                    "timeFrame": "9 months"
                },
                {
                    "measure": "Neonatal outcomes: birth weight",
                    "description": "birth weight (grams)",
                    "timeFrame": "9 months"
                },
                {
                    "measure": "Neonatal outcomes gestational age of delivery (weeks)",
                    "description": "gestational age of delivery (weeks)",
                    "timeFrame": "9 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Singleton gestation\n* Gestational age \\<24 weeks\n* Baseline Hb \u22659.0 and \\<11.0 with evidence of iron deficiency anemia\n\nIron deficiency anemia diagnosed (at any point in patient history) by:\n\n* Hb\\<11.0\n* Ferritin\\<30 and/or total iron saturation \\<20\n\nExclusion Criteria:\n\n* Sickle cell Disease (NOT sickle cell trait)\n* Evidence of acute anemia requiring transfusion or IV iron therapy\n* Major congenital or chromosomal anomaly\n* Previous use of IV iron in this pregnancy\n* Severe cardiac, renal, or liver disease\n* Autoimmune disease (ie Systemic Lupus Erythematosus (SLE)\n* Allergy or contraindication to either study drug\n* History of medication allergy, reaction to IV infusion, or reaction to Feraheme or other IV iron products",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rupsa C Boelig, MD",
                    "role": "CONTACT",
                    "phone": "215-955-9196",
                    "email": "rupsa.boelig@jefferson.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Thomas Jefferson University Hospital",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rupsa C Boelig, MD",
                            "role": "CONTACT",
                            "email": "rupsa.boelig@jefferson.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "After completion of planned primary and secondary analysis, IPD data may be available on request with completion of appropriate data sharing agreements",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "timeFrame": "1 year after publication of study results",
            "accessCriteria": "After completion of planned primary and secondary analysis, IPD data may be available on request with completion of appropriate data sharing agreements"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000740",
                    "term": "Anemia"
                },
                {
                    "id": "D000018798",
                    "term": "Anemia, Iron-Deficiency"
                },
                {
                    "id": "D000090463",
                    "term": "Iron Deficiencies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000019189",
                    "term": "Iron Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000000747",
                    "term": "Anemia, Hypochromic"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20857",
                    "name": "Anemia, Iron-Deficiency",
                    "asFound": "Iron Deficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2781",
                    "name": "Iron Deficiencies",
                    "asFound": "Iron Deficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "asFound": "Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21177",
                    "name": "Iron Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4077",
                    "name": "Anemia, Hypochromic",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000052203",
                    "term": "Ferrosoferric Oxide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006397",
                    "term": "Hematinics"
                },
                {
                    "id": "D000057947",
                    "term": "Parenteral Nutrition Solutions"
                },
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10533",
                    "name": "Iron",
                    "relevance": "LOW"
                },
                {
                    "id": "M26996",
                    "name": "Ferrosoferric Oxide",
                    "asFound": "Hemodynamics",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9485",
                    "name": "Hematinics",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M28934",
                    "name": "Parenteral Nutrition Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "T341",
                    "name": "Iron Supplement",
                    "asFound": "Minutes per",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "Mi",
                    "name": "Mineral"
                }
            ]
        }
    },
    "hasResults": false
}